# Retatrutide in type 2 diabetes: TRANSCEND-T2D-1 results

Source: https://pepvault.app/research/retatrutide-transcend-t2d-1-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Retatrutide](https://pepvault.app/research#retatrutide)

Randomized trial · people

# Retatrutide: HbA1c down up to 1.94% in TRANSCEND-T2D-1

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In adults with type 2 diabetes on diet and exercise alone, all three retatrutide doses lowered HbA1c and body weight more than placebo over 40 weeks.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 537
- **Published:** 2026
- **Journal:** Lancet

## What they tested

The researchers asked whether retatrutide as the only diabetes medicine lowers HbA1c and body weight in adults whose type 2 diabetes stayed above target despite diet and exercise.

## How the study was done

A randomized, double-blind, placebo-controlled phase 3 trial in 537 adults with type 2 diabetes, run across 48 clinics in three countries. Each person was assigned to one of three retatrutide doses (the 4 mg, 9 mg, and 12 mg arms) or to placebo (a dummy shot), given once a week under the skin for 40 weeks.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

HbA1c (a 3-month average of blood sugar) changed by -1.69% in the 4 mg arm, -1.86% in the 9 mg arm, and -1.94% in the 12 mg arm, compared with -0.81% on placebo. Against placebo, the differences were -0.88%, -1.04%, and -1.12%, all p<0.0001. Body weight changed by -11.5%, -13.9%, and -15.3% across the three retatrutide arms, compared with -2.6% on placebo. The most common side effects were mostly mild to moderate stomach and gut problems that eased over time; 2-5% on retatrutide and 0% on placebo stopped treatment because of side effects, no severe low blood sugar was seen, and the 2 deaths, both in the 4 mg arm, were judged unrelated to the drug.

## What it doesn’t show

The trial lasted 40 weeks, compared retatrutide only with placebo rather than other diabetes drugs, and included people with fairly recent diabetes (mean 2.5 years) using no other diabetes medicine. It was funded by Eli Lilly and Company.

## The paper

Bajaj et al. Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial. Lancet. 2026.

- [PubMed (PMID 42250575)](https://pubmed.ncbi.nlm.nih.gov/42250575/)
- [The paper (DOI 10.1016/S0140-6736(26)00967-0)](https://doi.org/10.1016/S0140-6736%2826%2900967-0)
- [ClinicalTrials.gov (NCT06354660)](https://clinicaltrials.gov/study/NCT06354660)

## The compound

- [Retatrutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## More studies on Retatrutide

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026) Meta-analysis · people · 2026
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Retatrutide: less hunger and overeating vs placebo at higher doses](https://pepvault.app/research/retatrutide-kanu-2025) Randomized trial · people · 2025
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

## The library

- [Retatrutide](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
